Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC

Clinical trial NCT01733589 · COMPLETED

Trial details

NCT number: NCT01733589
Sponsor: Zhejiang Cancer Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage III Non-small-Cell Lung Cancer

Start date: 2012-11-01
Primary completion: 2015-06-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.